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Abstract
Background: Antimicrobial usage in food producing animals is of major concern. A clear link between the extent
of use and the development of antimicrobial resistance has already been demonstrated. To evaluate strategies that
may reduce the antimicrobial usage while assuring pig health and welfare, it requires profound knowledge of
factors that are associated with antimicrobial usage. Data on biosecurity and herd management practices are
important parameters to identify risk factors which are related to a higher antimicrobial usage. To investigate
between-farm variations of high and low usage the treatment incidence (TI) per age group in 60 German farrow-
to-finish herds was qualitatively and quantitatively analysed and linked to biosecurity measures, and herd management
characteristics.
Results: Weaned pigs received most of the treatments (median TI = 487.6), followed by suckling pigs (median TI = 138.9).
Suckling pigs were treated with critically important antimicrobials (3rd and 4th generation cephalosporines) to a
remarkable extent. The number of sows present at site (p < 0.01) and a low score for external biosecurity (p = 0.06)
were associated with a higher antimicrobial usage in pigs from birth till slaughter. Herds with a higher treatment
incidence in growing pigs (TI 200 days): i) were located in a region with a high pig density (p < 0.01), ii) had a less strict
access check for visitors and personnel (p < 0.01) and iii) scored lower in the subcategory ‘cleaning and disinfection’
(internal biosecurity) (p < 0.01). Herds with a higher treatment incidence in breeding pigs weaned more piglets per sow
and year and scored better in the internal biosecurity level (p = 0.02).
Conclusions: With the main focus on the treatment incidence in pigs from birth till slaughter and in breeding pigs risk
factors for a high usage in these age groups were identified. The level of biosecurity of a herd was associated with the
amount of antimicrobials used. Therefore, the findings in this study indicate possible points of action in the reduction
and prudent use of antimicrobials in Germany. The active improvement of biosecurity measures could be a promising
alternative to reduce antimicrobial usage on herd level.
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Background
The modern pig production has grown to an efficient,
economically driven industry in the EU (European
Union). Farmers and veterinarians face various chal-
lenges to decrease the risk for disease in this intensive
livestock production system. To prevent mortality and
morbidity antimicrobials are an essential tool to treat
bacterial infections. But this therapy option to cure bac-
terial infections in veterinary and human medicine is
impeded due to the risk of selection for and spread of
antimicrobial resistance [1]. A clear link between the
extent of use and the development of antimicrobial re-
sistance has already been demonstrated [2–5]. In coun-
tries with a high antimicrobial usage (AMU), high
levels of antimicrobial resistance occurred [4]. Inter-
national organisations such as the EMA (European
Medicines Agency), WHO (World Health Organisation)
and the OIE (World Organisation for Animal Health) are
strongly recommending the implementation of monitor-
ing activities. Hence, several EU countries are already con-
ducting monitoring programmes for AMU [6–9].
Furthermore, the European Food Safety Authority (EFSA)
and the EMA released a Joint Scientific Opinion upon
measures to reduce AMU in animal husbandry and their
impact on antimicrobial resistance [10]. This plan empha-
sises the need of a holistic, multidisciplinary approach to
reduce AMU in all sectors related to public health.
Germany, with a total population of 28 million pigs is one
of the biggest pig producing countries in the EU [11]. The
absolute amount of antimicrobials used is correspondingly
high. One of the key elements to progress towards cor-
rective actions is to establish a basis for a comprehensive
understanding of extended AMU [12]. Reports on AMU
over several EU countries already exist [13]. These reports
however use national sales data of antimicrobials in kilo-
grammes or tons of active substance and relate these to
the biomass of the animal population in the different
reporting EU countries. Thus, a reallocation to a specific
species is not possible. Besides the aforementioned limita-
tion, the potency of an antimicrobial product is not con-
sidered in this quantification method [14].
Standards have been developed to measure AMU in a
consistent approach to explain differences in the extent
of and reasons for usage between EU member states
[13]. The ESVAC (European Surveillance Veterinary
Antimicrobial Consumption) report already provides
data on sales of antimicrobials for food producing ani-
mals but does not give insight on the distribution by
species and age. Just recently a study using a represen-
tative data set on the AMU provided details on the
quantitative and qualitative use in pig herds in
Germany [15]. The results showed that there are sig-
nificant differences in antimicrobial classes prescribed
and in the age pigs receive an antimicrobial treatment.
The treatment incidence (TI) based upon the “defined
daily dose” (DDD) can be calculated, if detailed infor-
mation on herd level on AMU (e.g. total amount of an-
timicrobials administered), as well as information on
the period at risk of receiving a treatment and the num-
ber of animals being treated at their respective weights
are provided [16–18]. Harmonized data collection is a
crucial starting point to explore association between
management factors, production parameters, preventive
measures and AMU on herd level. In order to progress
towards corrective actions, it is necessary to further in-
vestigate reasons for different usage patterns on differ-
ent farms and in different age groups and further
explore risk factors that are associated with a higher
usage on herd level.
According to several studies, the AMU varies be-
tween herds [1, 5, 16–19]. These variations may be re-
lated to differences in the herd health status, which is
partly influenced by herd characteristics like different
perspectives on biosecurity measures and disease pre-
ventions [12]. The improvement of biosecurity mea-
sures is an important approach to prevent the entry
and spread of pathogens in a herd and thus may reduce
the necessity of AMU [18, 19]. In order to differentiate
the biosecurity level of a certain herd, a comprehensive
and quantitative description of the level of biosecurity
is necessary. The risk-based biosecurity scoring system
(Biocheck.Ugent™) converts questions regarding the
biosecurity practices of a certain herd into a score for
its external (measures to prevent the introduction of
pathogens into a herd from outside), internal (measures
to reduce the spread of pathogens within a herd) and
overall biosecurity status [20]. The results can be used
to inform farmers and veterinarians on possible areas
for improvement of the biosecurity level and provide a
benchmarking by comparing the individual herd with
other herds that had already been evaluated by
Biocheck. Accordingly, this benchmarking method
may serve as an effective tool to stimulate the reduc-
tion of AMU.
The aim of this cross-sectional study was to identify
risk factors which contribute to a high AMU in 60
German farrow-to-finish herds. As a first step, the
AMU was described in a qualitative and quantitative
manner using the TI and a consensus “defined daily
dose animal” (DDDA) [21]. Subsequently, the biosecur-
ity measures and herd characteristics were analysed for
their associations with the AMU.
Materials and methods
Herd selection
The cross-sectional study was performed in three regions
with intensive pig production; Niedersachsen, Nordrhein-
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Westfalen and Mecklenburg-Vorpommern. These regions
represent approximately 64% of the total pig production
in Germany [22]. Only herds with at least 100 breeding
sows and 500 fattening pigs present were included in the
study. To allow comparison between the herds only
full-line (sows and fattening pigs present in one location)
or semi full-line herds (sow herds with 1:1 relation with
the fattening pig herd at a different location) were asked
to participate. Volunteering farmers were reached by dif-
ferent methods. The project was presented to consultancy
circles for pig owners and to farmers’ associations. More-
over, veterinarians specialised in pigs were asked to en-
courage clients fulfilling the inclusion criteria. Finally, 60
herds were enrolled in the study.
Herd visits and data collection
The herds were visited once on a convenient day be-
tween December 2012 and January 2014. All herds were
examined by one and the same investigator following a
standardised protocol. All participants were asked to
sign a contract, where anonymity of all collected data
was guaranteed. During the herd visit a questionnaire on
paper was completed by interviewing the farmer. Farms
were consecutively numbered (D1-D60) in order to an-
onymise the questionnaire. The questionnaire was basic-
ally divided into two parts. The first part included 21
open and closed questions concerning general herd
characteristics (e.g. number of sows, number of full-time
employees), antimicrobial treatments, disease incidences,
management practices and vaccination protocols.
Reproduction data were collected from the herd man-
agement system or provided by the farmers’ associations.
For the information on the disease incidence the farmers
were asked for the frequency of treatments (e.g. antimi-
crobials, electrolytes, probiotics, etc.) against certain dis-
ease symptoms per age category. For the suckling,
weaned and fattening pigs, five disease symptom
categories were defined comprising disorders of the
locomotive system (e.g. lameness), gastro-intestinal
tract, respiratory tract, central nervous system and
skin. For the sows two more categories summarising
diseases of the reproductive tract and the udder were
added. The answers were transferred to a
five-category-scale, where one was equal to never, two
was rarely, three occasionally, four regularly and five
commonly/always. To describe the workload per em-
ployee the number of breeding pigs per employee
(full-time equivalent) was calculated. The number of
pathogens vaccinated against was created by summing
up all vaccinations used in a herd (for sows, boars, gilts,
suckling, weaned and fattening pigs). For combined vac-
cines the single pathogens were accounted separately. The
second part of the questionnaire included 109 questions
concerning the biosecurity status of the herd (available
online http://www.biocheck.ugent.be). All information on
the herd management and biosecurity level corresponded
to the twelfth months preceding the herd visit. The herd
visit was completed by an inspection of the herd in order
to validate the answers given during the interview.
For quantitative and qualitative data on the anti-
microbial consumption the application and dispensing
records on the AMU of the preceding twelfth months
from every age and production group were collected.
These records are statutory documents for veterinar-
ians and farmers and were either provided by the
farmer (copy or photograph) or the herd veterinarian
(copy or E-mail) after receiving the permission to
provide these records [23]. Besides information on the
date of delivery, age group, identity of the animals,
product name, purchased volume, dosage per animal,
treatment duration, these forms specified the indica-
tion for the treatment. These variables are demanded
by national law [23]. Commercial in-feed medication
was not applied in the participating farms. Antimicro-
bial consumption data was anonymised using con-
secutive numbers (D1-D60). The assigned number
was identical to the number in the questionnaire. The
collected data was later entered in Excel 2010®
(Microsoft Corporation).
Quantification of antimicrobial usage
The application and dispensing records provided by the
herd veterinarians and farmers were used as an input for
the web based tool “ABcheck.UGent”, developed by
Ghent University, Belgium. First, the system converted
the amount of antimicrobials (in ml, l, g or kg) to active
substance, expressed in milligram. Subsequently, it
quantified the AMU for a specific herd by using the for-
mula first described by Timmerman et al. [16] which in-
cluded the period at risk, a standardised weight of the
animals, the number of animals at risk and a consensus
DDDA [21]. The obtained value was the treatment inci-
dence (TI) which is a technical unit of measurement
quantifying the number of animals out of a theoretical
group of 1000 animals receiving a daily treatment with
antimicrobials. This is equivalent to the number of days
an animal would have been treated with antimicrobials,
if it lived for a theoretical period of 1000 days. The TI
was calculated using the following formula [16]:
TI ¼ total amount of antimicrobials administered mgð Þ
DDDA
mg
kg
 
 number of days at risk  number of animals at risk
uniform weights for specific age category kgð Þ
 1000 pigs at risk
The numerator represents the total amount of antimi-
crobials administered in milligrams (mg) of active sub-
stance, which was applied to a certain group of animals
in a defined period (denominator). The DDDA’s used in
this study originated from a consensus DDDA list, which
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was previously developed by Postma et al. [21]. All anti-
microbial products licenced until December 2013 were
classified according to the WHO Anatomical Thera-
peutic Chemical (ATCvet) system. The days at risk for
each age category were defined as the time period a pig
could receive an antimicrobial treatment. For breeding
animals, it was set to 365 days, for suckling, weaned and
fattening pigs the rearing periods of the individual herds
were used. Combined TI’s were calculated for breeding
pigs (TI breeding pigs: sows, gilts and boars) and for pigs
from birth till slaughter (TI 200 days: suckling, weaned
and fattening pigs). The period at risk for pigs from birth
till slaughter was standardised to a 200 days period to
correct for differences in ages at slaughter between
herds. For the calculation of the TI 200 days, the sum of
the TI suckling pigs, weaned pigs and fattening pigs was
divided with the number of days for the actual rearing
period and finally multiplied with 200. Thus, the com-
parison of AMU between the herds was facilitated. To
enhance comparability uniform weights for the age cat-
egories (in kilogrammes) were applied; 2 kg for suckling
pigs, 7 kg for weaned pigs, 35 kg for fattening pigs, 60 kg
for gilts and 220 kg for sows. Because of the different ac-
tivity spectrum, the beta-lactams were evaluated separately
in two groups: aminopenicillines and benzylpenicillines.
Furthermore, graphs on the proportion of the used anti-
microbial classes per age group and administration route
were prepared to visualize the results.
Quantification of the biosecurity status
For assessing the biosecurity status of a herd in a standar-
dised way, the already validated risk-based biosecurity
quantification tool “Biocheck.UGent™” was used [20]. This
tool calculates a score for external, internal and overall
biosecurity and thus allows a comparison of the biosecur-
ity status of herds. Both parts are divided into six subcat-
egories, each consisting of two to 13 mainly dichotomous
and trichotomous questions. For external biosecurity these
are: 1. purchasing policy (e.g. pigs from same supplier,
health status documented, quarantine period), 2. removing
animals, manure, carcasses, 3. supply fodder, water, equip-
ment, 4. access check (e.g. availability of hygiene lock,
strict separation of dirty and clean area in hygiene lock), 5.
vermin, bird control, 6. location, environment (e.g. herd
located in an area with high density of pigs [average pig
density at municipality level > 300 pigs/km2], spotting of
wild boars). For internal biosecurity, these subcategories
are: 1. management diseases (e.g. availability of hospital
pens), 2. farrowing, suckling period (e.g. frequency of
cross-fostering of suckling pigs, frequency of manipulating
[vaccination, castration] suckling pigs), 3. nursery period
(e.g. all-in/all-out-management, mixing of different age
groups), 4. fattening period, 5. compartmentalizing, work-
ing lines, equipment and 6. cleaning, disinfection. In the
system every answer has a specific weight, depending on
its importance in disease prevention. In case of absence of
a biosecurity measure the score will be zero whereas in
the presence of specific measures a score from 0.5 to ten
is given (see detailed information on the scoring system in
the supplementary files by Laanen et al. [20]). The weights
of the questions were subsequently defined in a score for
each subcategory, for the internal and external biosecurity
and a total score, consisting of both internal and external
scores, each ranging from zero (total absence of any biose-
curity measure) to 100 (perfect biosecurity).
Statistical analysis
Data on herd characteristics (e.g. management, technical
parameters), biosecurity status, disease incidence and
AMU were first managed using Excel 2010® (Microsoft
Corporation). The results were analysed using descriptive
statistics in SPSS Statistics (IBM SPSS 22.0, USA). For
continuous variables the mean, median, minimum and
maximum value and standard deviation were assessed. If
continuous variables were not normally distributed a loga-
rithmic or square root transformation was performed. In
order to identify differences between low and high AMU,
farms below the median TI 200 days (group 1) and above
the median 200 days (group 2) were compared in terms of
biosecurity scores using an independent sample t-Test
with a significance level of 5% (p < 0.05). The threshold
value used to define low versus high TI 200 days was the
median TI 200 days of all participating farms (n = 60).To
identify possible associations between AMU, herd charac-
teristics, technical parameters and biosecurity status, the
focus was laid on two specific predictor variables
(outcome variables), namely the TI breeding pigs and the
TI 200 days. The variables (risk factors), which might in-
fluence AMU or were being influenced by AMU, were
then tested using univariable and subsequently multivari-
able linear regression models. The variables with p < 0.2 in
the univariable model were retained for the multivariable
model. To avoid multicollinearity, correlation between
retained variables was assessed by means of the Pearson’s
two-way-correlation coefficient and if the coefficient was
> 0.6, only the best fitting variable was included in the
multivariable model. The model was built by means of a
manual stepwise backward selection procedure. During
the modelling process confounding effects were evaluated
by reviewing changes in parameter estimates. Additionally,
residuals of the model were visually tested for homosce-
dasticity. All interaction between significant (p < 0.05) var-
iables in the final model were tested.
Results
Herd characteristics
The median number of sows was 300 (range 100–1510)
(Table 1). The median weaning age was 25.2 days (range
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19.3–32.6 days) and the median number of weaned pigs
per sow per year was 26.9 (range 21.1–32.2). A median of
107 breeding pigs (sows) per employee (range 50–450)
was calculated. Most of the farms had a batch farrowing
system of three-weeks (28/60), followed by one-week
(16/60), two-weeks (10/60), four-weeks (5/60) and
five-weeks (1/60).
Antimicrobial usage and disease incidence
Most of the antimicrobial treatments were administered
to suckling and weaned pigs with a median TI of 138.9
(range 8.1–1496.4) and 487.6 (range 8.5–1965.8), re-
spectively (Table 2). Median TIs for fattening pigs and
breeding pigs (sows, gilts and boars) were 51.7 and 42.0
per 1000 days at risk (ranges 0.0–399.2 and 0.2–204.5),
respectively. The median treatment incidence for pigs
from birth till slaughter, expressed as “TI 200 days”, was
242.8 (range 3.8–673.9). This means that pigs from birth
till slaughter were treated with a daily dose of antimicro-
bials for 48.5 days out of the 200 days of their expected
lifespan (Table 2). By the time of the AMU data collec-
tion a total of 281 generic products containing anti-
microbial substances were licenced for pigs in Germany
[21]. Suckling pigs were mainly treated with macrolides
(49%) (Fig. 1a) and weaned pig received
aminopenicillines (43%) the most (Fig. 1b). Moreover, in
suckling pigs the 3rd and 4th generation cephalosporines
(7%) and in weaned pigs the polymyxines (20%) were
used in a noteworthy amount. Among the fattening pigs,
aminopenicillines (49%) were mostly administered (Fig.
1c). The gilts and sows were mostly treated with tetracy-
clines (46%) (Fig. 1d). Over all age categories, aminope-
nicillines (36%), macrolides (18%) and tetracyclines
(17%) were administered the most (Fig. 1e). From all
antimicrobial substances used, 71% were administered
orally, while 29% were given by injection (Fig. 2). The
count and proportion of the five-category-scale for the
frequency of treatment against defined disease symp-
toms per age category are displayed in an additional file
(see Additional file 1). Treatments against lameness
(occasionally: 42%; regularly: 14%) and gastro-intestinal
(occasionally: 28%; regularly: 20%) diseases were com-
mon in suckling pigs. Weaned pigs were commonly
treated against lameness (occasionally: 50%; regularly:
7%) and gastro-intestinal (occasionally: 28%; regularly:
27%) diseases, but also against respiratory diseases
(occasionally: 48%; regularly: 10%). Fattening pigs were
mostly treated against lameness (occasionally: 27%;
regularly: 3%), respiratory (occasionally: 28%; regularly:
5%) and skin (occasionally: 28%; regularly: 5%) related
Table 1 Descriptive information on the herd characteristics and technical parameters of 60 farrow-to-finish herds in Germany
Parameter N Mean Median SD Min Max
Number of sows/ herd 60 396 300 299 100 1510
Number of litters/ sow/ year 60 2.36 2.37 0.88 2.12 2.53
Mortality till weaning (%) 60 15.1 15.3 5.5 3.3 30.4
Weaning age (days) 60 24.4 25.2 3.3 19.3 32.6
Number of weaned pigs/ sow/ year 60 27.3 26.9 2.6 21.1 32.2
Number of sows per employee 58a 130 107 64 50 450
Number of slaughtered pigs/ year 60 5306 3740 5657 1000 40,000
Average daily weight gain (g/day) 38a 811.2 800 43.8 720 900
Average feed conversion ratio (g/g)/ year 27a 2.75 2.72 0.13 2.4 2.95
Years experience farmer 60 24.9 25 10.2 5 45
Number of pathogens vaccinated against 60 6.9 7 1.5 4 10
aData was not available in all participating herds
Table 2 Descriptive information on the treatment incidence per age category
Parameter N Mean Median SD Min Max
TI suckling pigs 60 245.0 138.9 257.4 8.1 1496.4
TI weaned pigs 60 633.4 487.6 491.5 8.5 1965.8
TI fattening pigs 58a 51.7 19.4 77.1 0.0 399.2
TI 200 daysb 60 242.8 189.1 170.5 3.8 673.9
TI breeding pigs (gilts, sows, boars) 60 42.0 21.1 49.1 0.2 204.5
aTwo farms with missing values for the TI fattening pigs
bThe treatment incidence is defined as the number of pigs per 1000 pigs that receive a daily dose of antimicrobials. A TI 200 days is applied for pigs from birth till
slaughter for comparison between herds, assuming an expected lifespan of 200 days
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symptoms. Breeding pigs had more reported treatments
due to lameness (occasionally: 45%; regularly: 7%),
reproductive (occasionally: 30%; regularly: 5%) and
mastitis (occasionally: 38%; regularly: 12%) symptoms
(see Additional file 1).
Biosecurity scores
The biosecurity score in the studied herds showed vari-
ation in the different sub-categories and in the total scores
(Table 3). Compared to the median of the total internal
biosecurity (median = 55, range 37–82), the total score for
external biosecurity was higher (median = 70, range 50–
93). Among the external biosecurity sub-categories, the
highest median score was achieved for “purchasing policy”
with a score of 88 (range 30–100). The lowest score was
reached for “location and environment” with a score of 30
(range 0–100). For internal biosecurity the lowest scores
were obtained for “compartmentalizing, working lines,
equipment” with 39 (range 11–100) and “cleaning and dis-
infection” with 45 (range 0–88). The highest score was
seen for “fattening period” with 79 (range 21–91) and
“nursery period” with 71 (range 31–100).
Risk factors associated to a higher antimicrobial usage
Due to a right skewedness a LOG (logarithmic) trans-
formation of the TI breeding pigs and the number of
sows was needed to fit into the regression models. For
the outcome variable TI 200 days a square root trans-
formation was performed.
Farms belonging to the group 1 (below the median
TI 200 days) scored significantly better for some biosecur-
ity practices: in the external biosecurity they had better
(a) (b)
(c) (d)
(e)
Fig. 1 Proportion of the antimicrobial classes administered to suckling, weaned, fattening and breeding pigs. *TMPS: Sulfonamides and trimethoprim.
a Suckling pigs b Weaned pigs c Fattening pigs d Breeding pigs e Proportion over all groups
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biosecurity practices on personnel and visitors (access
check: p < 0.01) and were located in a more favorable re-
gion (location and environment: p < 0.01) with a for ex-
ample lower pig density (i.e. average pig density at
municipality level > 300 pigs/km2). In the internal biose-
curity group 1 scored significantly better in cleaning and
disinfection (p < 0.01) (Table 4). Moreover, the TI 200 days
was significantly higher in larger herds (p = 0.02) (herd
size expressed as the number of breeding pigs per herd)
(Table 5). A lower TI 200 days was associated with a
higher score for external biosecurity (p = 0.06). Regarding
the treatment incidence of breeding pigs, two factors
showing a significant effect (p < 0.05) on the TI breeding
pigs were retained in the multivariable model. The
number of weaned pigs per sow per year (p = 0.03) and
the internal biosecurity (p = 0.02) were positively associ-
ated with a higher treatment incidence in the breeding
sows (Table 5). Herds with a higher AMU in the breeding
pigs weaned more pigs per sow per year and scored better
in the internal biosecurity (adjusted r2 = 0.17).
Discussion
Study design
The objective of the study was to describe the AMU in
pig herds and to identify herd management and biose-
curity characteristics influencing this usage. To identify
risk factors associated with a higher AMU in the pig sec-
tor, our field study focussed on farrow-to-finish farms. It
Fig. 2 Proportion of the administration route (oral and parenteral) of the antimicrobial treatments (treatment incidence)
Table 3 Descriptive information on the biosecurity scores obtained in Biocheck.UGent™ on external and internal biosecurity and their
specific subcategories
Parameter N Mean Median SD Min Max
External 60 70 70 9 50 93
Purchasing policy 60 84 88 14 30 100
Removing animals, manure, carcasses 60 79 79 10 50 100
Supply fodder, water, equipment 60 47 46 14 27 90
Access check 60 71 71 16 35 100
Vermin, bird control 60 71 70 19 30 100
Location, environment 60 38 30 31 0 100
Internal 60 55 55 9 37 82
Management diseases 60 64 60 25 40 100
Farrowing, suckling period 60 52 50 21 0 93
Nursery period 60 73 71 17 36 100
Fattening period 60 79 79 17 21 93
Compartmentalizing, working lines, equipment 60 41 39 15 11 100
Cleaning, disinfection 60 43 45 19 0 88
Raasch et al. Porcine Health Management            (2018) 4:30 Page 7 of 14
has to be pointed out, that in observational studies of
this type (cross-sectional) the levels of usage might be
subject to selection bias. The participation depended on
voluntary basis and maybe these farmers were in general
more interested and hence representing the better per-
forming herds. Moreover, we have to consider, that the
obtained associations are the results of a cross-sectional
study, not allowing to make direct causal conclusions.
The data and information collected was reviewed and
checked using visual inspection and documentation to
minimize recall bias.
The average herd size (number of breeding pigs) in
our sampled herds was 396 (median 300) sows per
herd. Nationally the average number of breeding pigs
(sow, gilts and boars) per farm is 145 [22]. This
suggested that our sample population represented the
larger herds. Most of the herds were located in Nieder-
sachsen and Nordrhein-Westfalen where the average
pig density is > 179 pigs/km2 and > 209 pigs/km2 respect-
ively which is above the national average (75 pigs/km2)
[24]. These criteria (volunteer farmers, herd size and pig
density) resulted in a possible participation bias. On the
other hand, the participating herds were located in regions
where the majority of the German pig production takes
place, suggesting that the results gave a good insight of
the associations between pig production, biosecurity and
AMU in German farrow-to-finish farms.
Antimicrobial usage and disease incidence
To be able to compare the differences in the AMU in an
objective manner a standardised approach was needed.
To interpret the amount of consumed antimicrobials it
is not sufficient to rely on data on purchased antimicro-
bials in kilogram [14, 17]. The provision of AMU data
via pharmacies or other central dispensary locations is
not suitable for Germany. Due to the legal compliance
the application and dispensing records provided by the
farmer or veterinarian yielded reliable data on the AMU
on herd level [23]. Commercial in-feed medication was
not recorded and applied in the participating farms.
Only very few feed mills have the manufacturing author-
isation to produce commercial in-feed medication [25].
The production is complex and cost-intensive and ac-
cordingly this method to apply antimicrobials in
Table 4 Comparison of the treatment incidence (mean and standard deviation) and biosecurity scores (two-sample t-Test for equal
means) of farms below (n = 30) and above (n = 30) the median TI 200 days (186.1)
Group 1: Farms < median
TI 200 days (na=30)
Group 2: Farms > median
TI 200 days (na=30)
P-value3
Treatment incidence Mean (SDb)
TI suckling pigs 162.0 (185.1) 328.2 (297.5)
TI weaned pigs 284.4 (168.5) 982.4 (468.5)
TI fattening pigs 21.9 (32.0) 84.0 (95.1)
TI 200 days 113.0 (53.0) 372.6 (146.4)
TI breeding pigs 45.0 (53.0) 39.2 (46.0)
Biosecurity scores Mean (SDb)
External biosecurity
Purchasing policy 87.9 (10.0) 88.1 (8.8) 0.94
Removing animals, manure, carcasses 80.7 (9.8) 77.5 (11.1) 0.24
Supply fodder, water, equipment 48.7 (15.2) 43.5 (12.4) 0.15
Access check 76.7 (15.3) 65.9 (15.0) < 0.01
Vermin, bird control 75.0 (18.7) 67.0 (20.7) 0.11
Location, environment 58.0 (27.6) 20.0 (22.1) < 0.01
Internal biosecurity
Management diseases 55.1 (22.0) 49.8 (19.1) 0.33
Farrowing, suckling period 69.2 (16.2) 75.3 (18.0) 0.17
Nursery period 78.5 (16.0) 77.9 (19.0) 0.91
Fattening period 40.4 (13.2) 42.5 (17.0) 0.59
Compartmentalizing, working lines, equipment 43.0 (20.2) 45.6 (18.2) 0.56
Cleaning, disinfection 74.2 (8.2) 66.2 (8.1) < 0.01
3Applied level of significance 5% (p < 0.05). Significant differences are highlighted in black and bold
an Number
bSD Standard deviation
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Germany is almost obsolete [25]. Several studies investi-
gated different methods for the quantification of anti-
microbial consumption [16, 26, 27]. In this study the
treatment incidence based on a DDDA which is also
proposed by the ESVAC consortium was applied [16, 21,
28]. The method allows the comparison between farms,
regions and countries and is based on the dose and
weight of the pharmacologically active ingredient. The
DDDAs used in this study were developed to quantify
the amount of antimicrobials administered to the pigs.
The most transparent method to establish a consensus
DDDA was to take the mean of all authorized products
Table 5 Statistical results of univariable and multivariable linear models for the outcomes TI 200 days and TI breeding pigs
1Light gray values in the univariable model indicate that these factors were not significant (p < 0.20) in the univariable model. In the multivariable model the p-values
which are significant with p < 0.05 are black and bold, 0.05 < p < 0.10 are black and p > 0.10 are light gray
aSqrt Square root transformation
bLOG Log transformation
cCat Categorical variable
dData was not available in all participating herds
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with the same active ingredient and administration route
[21]. Most of the treatments were used in the youngest
animals, the suckling and weaned pigs. Particularly in
these age groups a large between-farm variance has been
identified. These differences of the amount of antimicro-
bials used in suckling and weaned pigs were also de-
scribed in other countries, including Belgium and France
[16–18]. Furthermore, it was suggested, that this vari-
ance between the farms was related to differences of dis-
ease incidence, management factors, biosecurity
measures and socioeconomic factors, like farmers’ and
veterinarians’ attitude [29–31].
Regarding antimicrobial classes considered to be espe-
cially critical to human medicine, we identified a rela-
tively frequent usage of third generation cephalosporines
in suckling pigs. These products promise advantages to
the farmer, because they are usually long and potent act-
ing and can be administered in lower doses [15]. They
were most likely applied to suckling pigs after routine
manipulation such as castration and teeth clipping.
Similar to our findings, in the study of Callens et al. [5]
the use of more modern antimicrobials (e.g. cephalos-
porines) increased. Yet these products belong to the
most critical important antimicrobials according to the
WHO list. Therefore, it is highly unwanted to see such a
high and increasing use. In some European countries
(e.g. Belgium, The Netherlands, Denmark) the use of
these third and fourth generation cephalosporines in
pigs has been highly regulated or even banned [9, 32,
33]. The most common indication for a treatment in
suckling and weaned pigs were disease symptoms related
to the gastro-intestinal and locomotive system (e.g.
lameness). The frequent use of aminopenicillins, macro-
lides and polymyxines in these age groups indicated, that
these symptoms were most likely treated with these anti-
microbial classes. Especially the frequent application of
macrolides and polymyxines (mainly colistin) is rather
worrying, since in the ‘Guidelines for the prudent use of
antimicrobials in veterinary medicine’ it is recommended
to reduce both macrolides and colistin [34]. Moreover,
the recent discovery of plasmid-mediated resistance to
colistin via the genes mcr-1, mcr-2, mcr-3, mcr-4 and
mcr-5, even more demand for a restrictive use [35–38].
Farmers reported, that fattening pigs were commonly
treated against respiratory symptoms. The high amounts
of aminopenicillins in this age group presumed a fre-
quent use of this antimicrobial class. Diseases of the re-
productive tract in breeding pigs were mainly treated
with tetracyclines. Moreover, farmers described, that
treatments against disorders of the locomotive system in
breeding pigs increased since 2013. According to the
‘Animal Protection Keeping of Production Animals
Order’ (TierSchNutztV) group housing of sows is obliga-
tory since January 2013 [39]. Farmers observed increased
ranking fights in the groups after weaning of the piglets.
Hence, they could have reported more treatments and
losses due to disorders of the locomotive system. When
analysing the treatment records in our study, especially
the antimicrobials applied to the suckling and weaned
pigs were administered regularly assuming reoccurring
clinical diseases in these age groups and thus resembling
treatments in a preventive manner. Callens et al. [5] also
reported, that the majority of strategic group treatments
in pigs are given during the suckling and nursery period.
The prophylactic use (treatment of healthy animals) of
antimicrobials must be avoided in Germany [34].
Moreover, the median TI in the weaned pigs (TI = 487.6)
indicates, that animals were treated 49% of the days in
the nursery period. A TI over 1000, which was found in
19 out of 60 farms, implies that the animals were treated
1000/1000 days, or 100% of their lifespan/period dur-
ation. Accordingly, the treatment method resembles
more a preventive rather than a metaphylactic (treat-
ment of clinically healthy animals belonging to the same
group or pen as animals with clinical symptoms [40]) or
curative treatment.
Biosecurity status
The prevention of the introduction of porcine pathogens
into pig herds is still a challenging task for farmers and
herd veterinarians. Biosecurity is an important tool to
maintain the health status of pig herds [41]. The assess-
ment of the level of biosecurity of the participating herds
and the derived information was used to analyse the as-
sociations between parameters (biosecurity level, man-
agement parameters and AMU) measured over the
preceding twelfth months. In general, it could not be
ruled out, that certain biosecurity measures have chan-
ged over the preceding year before the herd visit, e.g.
due to disease outbreaks, so that the scores might be
different from the average at the point of the data collec-
tion. Compared to the overall score for external
biosecurity (measures to prevent the introduction of
pathogens into a herd from outside), the score for in-
ternal biosecurity (measures to reduce the spread of
pathogens within the herd) was lower, which is in line
with the findings of Laanen et al. [18]. Other studies
showed that the level of biosecurity is influenced by the
herd size, suggesting that larger herds tend to have a
higher biosecurity status [18, 42–44]. According to Laa-
nen et al. [18] it is easier for larger farms to implement a
higher level of external and internal biosecurity which
might help to achieve a lower level of AMU. In general,
it is suggested, that an improved biosecurity leads to a
better health status and thus to a reduced need of anti-
microbials. But in contrast, the obtained score for in-
ternal biosecurity in our study was positively associated
with the treatment incidence (TI breeding pigs). One
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possible explanation for this association could be the in-
tensified improvement of internal biosecurity measures
due to a current high infection pressure in the herds
which led to a higher AMU. Furthermore, farmers with
a higher internal biosecurity score might follow an over-
all precautionary principle and are prone to a faster anti-
microbial treatment. It could also be suggested, that on
larger farms more attention is paid to the internal biose-
curity subcategories like disease management, working
lines, compartmentalizing etc. These findings were pre-
viously reported by other studies [18, 42–44]. The nega-
tive association between the subcategory “location and
environment” (external biosecurity) and the treatment
incidence of pigs from birth till slaughter emphasized
the importance of implementing biosecurity measures to
prevent pathogens to enter a herd.
Risk factors associated to a higher antimicrobial usage
The aim of this study was to describe and analyse risk
factors for a high AMU in German farrow-to-finish
farms. In order to explore farms with a higher usage in
detail, we compared farms below (group 1) and above
(group 2) the median TI 200 days. We observed, that
farms belonging to group 2 most likely applied more
antimicrobial treatments throughout the whole produc-
tion line (from suckling to fattening pig) and not to one
specific age group. Based on experience, most of the
farmers know the critical time points, when their pigs
get ill. At these critical time points farmers applied more
antimicrobial treatments [5, 16]. But in contrast, these
obvious differences were not observed in the treatment
incidence in breeding pigs. The results showed, that
breeding pigs received less treatments compared to
growing pigs. Thus, the observed differences in the treat-
ment incidence might be more pronounced in the suck-
ling, weaned and fattening pigs. Significant differences
between group 1 and 2 were observed in the biosecurity
scores. A risk factor for a higher AMU was identified for
farms, which were located in densely populated pig areas
and tended to have worse biosecurity practices for visi-
tors and personnel (external biosecurity). This is in ac-
cordance to the study by Collineau et al. [45], who
described the profile of ‘top-farms’ in terms of low
AMU and high technical performance. Direct associ-
ation of the level of external biosecurity and AMU was
described in Postma et al. [46], where a better external
biosecurity was associated with a lower AMU in pigs from
birth till slaughter. This finding was confirmed in our
study where a nearly significant association between the
level of external biosecurity and TI 200 days (p = 0.06) also
suggest that a lower score for external biosecurity results
in more antimicrobial treatments for pigs from birth till
slaughter. The introduction of pathogens from an outside
source increases the risk of disease onset in pig husbandry
[44–46]. Since external biosecurity reduces the risk of en-
trance of pathogens into a herd and exit of pathogens out
of a herd, a higher level of protection might reduce the
disease pressure and thus reduce the need for antimicro-
bial treatments. Other studies demonstrated a strong cor-
relation of external and internal biosecurity [47] and a
reduced need for antimicrobial treatments in herds with a
better internal biosecurity [18]. We observed, that farms
above the median TI 200 days also scored lower in the
subcategory ‘cleaning and disinfection’. The correct pro-
cedure of cleaning and disinfecting compartments and
materials will reduce the risk of transmitting pathogens,
which was already described for several pathogens like
Salmonella spp., Campylobacter spp. and Listeria monocy-
togenes [48, 49]. In a study by Laanen et al. [18], a better
score for internal biosecurity resulted in a lower AMU.
Thus the improvement of internal biosecurity on herd
level (e.g. strict hygiene protocol, all-in-all-out practice) is
a rather simple option to reduce the necessity to use anti-
microbials [50]. But in contrast we observed a significant
negative association between internal biosecurity and
AMU in breeding pigs. We have no explanation for this
finding, but as mentioned above, the total AMU in breed-
ing pigs was substantially lower than in growing pigs.
Since the majority of antimicrobial treatments were used
in the growing pigs, where we identified a nearly signifi-
cant positive association between external biosecurity and
AMU, more weight is given to this association. Thus, to
aim at a reduced AMU, the use of antimicrobials in the
growing phase would need to be addressed first. The mul-
tivariable linear regression model highlighted, that the TI
200 days was significantly higher in herds with more
breeding sows present. Herds with more breeding sows
usually work in a one-week-batch-farrowing-system to
keep smaller groups and reduce the workload peaks in the
more intensive periods around farrowing. In this produc-
tion rhythm the piglets are usually weaned at a lower age
(average of 21 days). The process of weaning introduces a
number of stress factors that may influence the immune
function and intestinal microflora of weaned pigs. These
disturbances might challenge the risk of enteric disorders
such as post-weaning colibacillosis (PWC), which is
mainly caused by enterotoxigenic Escherichia coli (ETEC)
[51]. Hence it could be suggested, that weaning at a lower
age increases the risk for infection due to an immature en-
teric microflora. Weaning earlier than 21 days of age is
banned in the EU and the legislation might enforce a
minimum of 28 days [52]. According to Postma et al. [46]
a higher weaning age was associated with a lower neces-
sity for antimicrobial therapy. Moreover, one of the several
factors determining the differences in AMU between
countries might be related to the differences in the wean-
ing age. Scandinavian countries like Sweden wean the pigs
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closer to 35 days of age and have a low usage of antimicro-
bials compared to other EU countries [1].
We showed that farms with a higher treatment inci-
dence for breeding pigs significantly weaned more pig-
lets per sow and year (WSY). One possible explanation
could be the more active involvement of the farmer
during the farrowing process. Since that is the period of
antimicrobial treatments for sows normally, the survival
rate of the piglets increased, resulting in more weaned
pigs per sow and year [53, 54]. Another possible explan-
ation is an increased sensitivity to disease as high
productive sows might require more antimicrobial treat-
ments as suggested by Postma et al. [46]. Moreover
Postma et al. [46] suggested, that the farrowing rate
might increase due to a positive effect of AMU on the
incidence of mastitis and endometritis. A good health
status of the sow might also improve the nursing abil-
ities. Thus, the transfer of maternal derived antibodies to
the piglets is optimized.
Conclusion
In conclusion this study conducted the first attempt to
identify associations between AMU and herd-level man-
agement factors in 60 German farrow-to-finish farms.
Suckling and weaned pigs received the most antimicro-
bial treatments and were mainly treated with macrolides
and aminopenicillines, respectively. Antimicrobial sub-
stances were commonly administered orally. Biosecurity
scores showed large variations between the studied
herds. Compared to the internal biosecurity score,
higher scores were obtained for the external biosecurity.
Farms with a high AMU in pigs from birth till slaughter
generally accounted for a higher AMU in suckling,
weaned and fattening pigs. Moreover, they were located
in a less favorable region with a high pig density, had
less strict hygiene regulations on visitors and personnel
and a worse cleaning and disinfection regime compared
to farms with a lower usage. Thus, the improvement of
biosecurity practices could be an important tool to re-
duce the necessity of AMU. For herds with a higher
treatment incidence in breeding pigs and pigs from birth
till slaughter we identified associated risk factors like the
herd size and biosecurity status. Farms with a higher
AMU might be more strictly adhering to routine habits
to treat their animals. Breaking the routines trough guid-
ance of a prudent AMU might reduce the necessity of
antimicrobial treatments. The results of this study sug-
gest that the main focus for reducing AMU should be
on growing pigs and farms with a high AMU since this
most likely will have the best effect. This enhanced
knowledge of risk factors for a higher AMU might sup-
port and specify farm advice and policy making towards
a more prudent use of antimicrobials.
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